Robert J. Garland

Director/Board Member at

Cardioxyl Pharmaceuticals LLC

Health Technology

Consumer Services

Retail Trade

Profile

Robert J.
Garland is currently a Director at Cardioxyl Pharmaceuticals LLC.
He previously worked as a Director at Novalar Pharmaceuticals, Inc., Zyngenia, Inc., Trevena, Inc., Sagimet Biosciences, Inc., Cleave Therapeutics, Inc., and Surface Oncology, Inc. He also worked as a Principal at McKinsey & Co., Inc. and a Venture Partner at NEA Management Co. LLC.
Garland received his undergraduate degree from Rice University, his graduate degree and MBA from the University of California, Berkeley, and his doctorate from Baylor College of Medicine.

Robert J. Garland active positions

Companies	Position	Start
Cardioxyl Pharmaceuticals LLC Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases	Director/Board Member	-

All active positions of Robert J. Garland

Former positions of Robert J. Garland

Companies	Position	End
SURFACE ONCOLOGY, INC.	Director/Board Member	-
SAGIMET BIOSCIENCES INC.	Director/Board Member	-
Cleave Therapeutics, Inc. Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment	Director/Board Member	-
Novalar Pharmaceuticals, Inc. Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Director/Board Member	-
Zyngenia, Inc. Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics	Director/Board Member	-

See the detail of Robert J. Garland's experience

Training of Robert J. Garland

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert J. Garland's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Novalar Pharmaceuticals, Inc. Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
Cardioxyl Pharmaceuticals LLC Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases	Health Technology
Zyngenia, Inc. Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics	Retail Trade
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Rice University Rice University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
NEA Management Co. LLC NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements.	Finance
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Baylor College of Medicine Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trevena, Inc. Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system	Health Technology
Sagimet Biosciences, Inc. Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases	Health Technology
Cleave Therapeutics, Inc. Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment	Health Technology
Surface Oncology, Inc. Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies	Health Technology